Thank you, Mr. Chairman. With regard to the never-ending quest for finding better and more innovative ways of trying to get to the smoking public, particularly to youth, I think there have been many programs; however, they have an extended shelf life, where after people have looked at them for a certain period of time, they aren't interested.

The Pauktuutit organization has negotiated some funds from the federal government, so they are going to try to take a different approach and go on a campaign for encouraging people to become non-smokers. Throughout their tranquillity, they become as stressed as everyone else. We just have to keep finding different approaches because an approach can be very valid, but it only lasts so long and people look through it. It doesn't have the impact for very long, so we just have to keep looking for newer and more innovative ways.

Regarding the area of concern about extended health benefits on pharmacare, there is a list and we've expanded it from time to time. We've dropped some drugs that really weren't necessary or weren't used, and added on according to the requirements and the needs of the general public. So we continue to do that under extended health benefits. So if there is a case to be made, we can't always come to a positive conclusion, but the Department of Health has been fairly responsive to requests that have been very critical and made some changes to the ongoing list of what will be covered under the extended health care benefits and we will continue to do so. Thank you.